| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,773 |
1,372 |
$135K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,790 |
1,502 |
$89K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
481 |
347 |
$35K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
387 |
341 |
$29K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
123 |
82 |
$17K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
265 |
212 |
$13K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
132 |
111 |
$10K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
149 |
119 |
$10K |
| 96127 |
|
609 |
504 |
$10K |
| 96160 |
|
421 |
346 |
$6K |
| 90686 |
|
466 |
361 |
$6K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
134 |
100 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
56 |
45 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
72 |
60 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
130 |
105 |
$2K |
| 90670 |
|
67 |
59 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
57 |
27 |
$1K |
| 83655 |
|
57 |
48 |
$676.02 |
| 90619 |
|
43 |
26 |
$656.17 |
| 90656 |
|
26 |
24 |
$434.46 |
| 36416 |
|
102 |
88 |
$412.05 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
16 |
14 |
$233.60 |
| 90698 |
|
15 |
14 |
$96.00 |
| 85018 |
|
21 |
13 |
$46.82 |
| 3008F |
|
1,064 |
910 |
$0.00 |
| 97802 |
|
13 |
13 |
$0.00 |
| 1036F |
|
63 |
57 |
$0.00 |
| 1220F |
|
63 |
57 |
$0.00 |
| 1003F |
|
1,131 |
958 |
$0.00 |
| 1160F |
|
708 |
595 |
$0.00 |
| 4274F |
|
363 |
288 |
$0.00 |
| 3210F |
|
21 |
18 |
$0.00 |